Related Experiment Video
Updated: Jun 28, 2026

Chromogenic In Situ Hybridization as a Tool for HPV-Related Head and Neck Cancer Diagnosis
Published on: June 14, 2019
Human papillomavirus testing for primary cervical cancer screening
Carolyn D Runowicz1, Stephanie Garozzo
1University of Connecticut School of Medicine, 263 Farmington Avenue, Farmington, CT 06030, USA. crunowicz@uchc.edu
Abstract:
With our understanding of human papillomavirus (HPV) and cervical cancer, the availability of HPV testing, and the known limitations of cervical cytology, it is time to reassess cervical cancer screening technologies. This article reviews recent randomized trials comparing primary HPV testing with cervical cytology in screening for cervical cancer, and also analyzes the impact of the HPV vaccine on screening cytology.
Related Concept Videos
Genital Herpes
Herpes
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
